Trademark Overview
On Wednesday, August 2, 2023, a trademark application was filed for TAAV with the United States Patent and Trademark Office. The USPTO has given the TAAV trademark a serial number of 79378254. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2024. This trademark is owned by TAAV Biomanufacturing Solutions, S.L.U.. The TAAV trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; biotechnological product, namely, viral DNA vector for delivery of genes and other materials for medical purposes; biotechnological product, namely, RNA and transcriptional targeting promoters to a biological cell for medical purposes; DNA for production of viral vectors for medical and veterinary purposes; none of the aforesaid being or including cell growth media
Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in agri-biotechnology and nanotechnology other than for medical and veterinary purposes; biological and biochemical reagents forming a gene analysis system, namely, RNA polymerase, DNA plasmid vectors and RNA markers for scientific or research purposes; diagnostic reagents for scientific or research purposes, namely, a kit primarily composed of a DNA plasmid vectors; none of the aforesaid being or including cell growth media
Scientific and technological services, namely, research and design in the field of DNA research and development; chemical and biological analysis and research services; scientific research in the field of DNA; scientific research and development in the field of creation of DNA extracts; scientific research, analysis, design and development relating to DNA based pharmaceutical drugs and therapies; scientific research and development in the fields of gene therapy, diagnostics, agri-biotechnology and nanotechnology; consultancy in the fields of agri-biotechnology and nano technology; consultancy relating to scientific research and development in the fields of gene therapy, diagnostics and DNA analysis; none of the aforesaid services relating to cell growth media
